Trimetozine

Trimetozine
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 635-41-6
PubChem (CID) 12478
ChemSpider 11968
UNII 31EPT7G9PL YesY
ChEMBL CHEMBL1697853
ECHA InfoCard 100.010.215
Chemical and physical data
Formula C14H19NO5
Molar mass 281.304 g/mol
3D model (Jmol) Interactive image

Trimetozine (Opalene, Trimolide, Trioxazine) is a sedative that has been marketed in Europe since 1959.[1][2] It also has mild tranquilizing effects and has been used in the treatment of anxiety.[3][4] Its mechanism of action is unclear.

References

  1. Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. p. 1932. ISBN 3-88763-075-0.
  2. David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
  3. Taverna P, Ferrari G (June 1970). "[Clinical trial of a new tranquilizing agent: trioxazine]". Minerva Medica (in Italian). 61 (46): 2574–90. PMID 5425739.
  4. Shpak VM; Shcheglova AIu (August 1968). "[Trioxazine in the treatment of night anxiety in children]". Pediatriia (in Russian). 47 (8): 76–7. PMID 5730033.
This article is issued from Wikipedia - version of the 10/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.